Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer

Introduction Sentinel lymph node (SLN) detection has been shown to be accurate in detecting lymph node involvement in early-stage cervical cancer. The objective of this study was to evaluate the accuracy of frozen section examination in the assessment of SLN status, with the aim of adequately driving the intra-operative decision. Methods We designed a retrospective study including patients from two comprehensive cancer centers between January 2001 and December 2018 with early-stage cervical cancer (IA1-IB2 according to International Federation of Gynecology and Obstetrics (FIGO) 2018) undergoing SLN dissection. The SLN procedure was performed using a cervical injection with technetium-99m combined with blue dye or indocyanine green in most cases. Results A total of 176 patients fulfilled inclusion criteria. Bilateral mapping was detected in 153 (86.7%) of them. Nineteen of these patients (12.4%) had SLN involvement: 13 with macrometastases, three with micrometastases and three with isolated tumor cells (ITC). Macrometastatic disease was missed on frozen section in 3/13 FIGO 2018 stage IIIC patients. The three patients with ITC were also missed by frozen section examination. Considering only macrometastases as lymph node involvement, frozen section sensitivity was 76.9% (95% CI 49.7 to 91.8) and negative predictive value (NPV) was 97.9% (95% CI 94.0 to 99.3) in patients with bilateral detection. Including micrometastases, sensitivity was 81.2% (95% CI 57.0 to 93.4) and NPV remained at 97.9% (95% CI 93.9 to 99.3). Conclusions With a prevalence of final-stage IIIC in patients with pre-operative early-stage cervical cancer of the order of 10% in this series, the NPV of frozen section examination of SLN is very high, with an inferior limit of the CI superior to 94%. Diagnostic accuracy remains acceptable even if micrometastases are considered. The impact of missed ITC has not been established. Frozen section examination can be incorporated in the intra-operative decision algorithm.

[1]  P. Hillemanns,et al.  SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study , 2019, International Journal of Gynecological Cancer.

[2]  R. Pareja Impact of ‘low-volume’ metastasis in sentinel lymph nodes: reconsidering options for no further treatment , 2019, International Journal of Gynecological Cancer.

[3]  C. Colpaert,et al.  Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol Oncol 2019;152:202–7 , 2019, Gynecologic oncology reports.

[4]  P. Mathevet,et al.  Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial , 2019, International Journal of Gynecologic Cancer.

[5]  P. Dundr,et al.  A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX) , 2019, International Journal of Gynecologic Cancer.

[6]  R. Kučera,et al.  One‐step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients , 2018, Journal of surgical oncology.

[7]  D. Cibula,et al.  Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. , 2019, Gynecologic oncology.

[8]  D. Aoki,et al.  Cancer of the cervix uteri , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  A. Weaver,et al.  Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging , 2018, Annals of Surgical Oncology.

[10]  R. Pötter,et al.  The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. , 2018, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[11]  S. Baba,et al.  Value of Intraoperative Cytological and Pathological Sentinel Lymph Node Diagnosis in Fertility-Sparing Trachelectomy for Early-Stage Cervical Cancer , 2017, Oncology.

[12]  M. Munsell,et al.  Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. , 2017, Gynecologic oncology.

[13]  F. Ghezzi,et al.  From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach , 2016, Annals of Surgical Oncology.

[14]  A. Oliani,et al.  Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence , 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[15]  E. Leung,et al.  Cancer of the cervix uteri , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  D. Querleu,et al.  Accuracy of intraoperative pathological examination of SLN in cervical cancer. , 2013, Gynecologic oncology.

[17]  N. Yaegashi,et al.  Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method. , 2013, Gynecologic oncology.

[18]  L. Dušek,et al.  High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. , 2013, Gynecologic oncology.

[19]  R. Rouzier,et al.  Comparison of Diagnostic Accuracy of Frozen Section with Imprint Cytology for Intraoperative Examination of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Results of Senti-Endo Study , 2012, Annals of Surgical Oncology.

[20]  G. Kenter,et al.  Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. , 2012, Gynecologic oncology.

[21]  A. Bats,et al.  Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. , 2011, Gynecologic oncology.

[22]  G. Chatellier,et al.  Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Querleu,et al.  Incidence of micrometastases in histologically negative para-aortic lymph nodes in advanced cervical cancer patients. , 2010, Gynecologic oncology.

[24]  Keun Ho Lee,et al.  HPV status in sentinel nodes might be a prognostic factor in cervical cancer. , 2007, Gynecologic oncology.

[25]  W. Ye,et al.  Identification of Micrometastases in Histologically Negative Lymph Nodes of Early-Stage Cervical Cancer Patients , 2004, Obstetrics and gynecology.